Pacira Pharmaceuticals Inc.

(PCRX) Trade

By |

Profile

Pacira Pharmaceuticals is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and commercialization of pharmaceutical products, primarily for use in hospitals and ambulatory surgery centers. The company focuses its product candidates within the United States, and intends to out-license commercialization rights for other territories. Pacira aims to retain significant control over the development process and commercial execution for its product candidates.

Contact Information

Website: www.pacira.com
Email: Susan.Mesco@pacira.com
Main Phone: +1 973 254-3560
Address: 5 Sylvan Way
Address 2: Suite 300
State: NJ
City / Town: Parsippany
Country: USA
Postal Code: 07054

Issuer Information

Exchange: NGS
CEO: David M. Stack
Employees: 489
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Pacira Pharmaceuticals is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and commercialization of pharmaceutical products, primarily for use in hospitals and ambulatory surgery centers. The company focuses its product candidates within the United States, and intends to out-license commercialization rights for other territories. Pacira aims to retain significant control over the development process and commercial execution for its product candidates.

Contact Information

Website: www.pacira.com
Email: Susan.Mesco@pacira.com
Main Phone: +1 973 254-3560
Address: 5 Sylvan Way
Address 2: Suite 300
State: NJ
City / Town: Parsippany
Country: USA
Postal Code: 07054

Issuer Information

Exchange: NGS
CEO: David M. Stack
Employees: 489
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 40.04 $ 1.31 (3.38%)
Last Price 40.04 Change $ 1.31 Change % 3.38 Tick N/A
Bid N/A Bid Size 0.00 Ask 40.55 Ask Size 100.00
Open 38.91 High 40.32 Low 38.61 Prev Close 38.73
Last Trade Volume 559,235 52 Wk Hi 55.00 52 Wk Low 26.95
Market Cap 1.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,114,217.00 EPS (TTM) -0.10 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 13 34
Number of Buys 2 11
Number of Sells 11 23
Net Activity -24466 -29061
Last 10 Buys Shares
Mark A. Kronenfeld 1,000
Mark Froimson 1,000
Scott Braunstein 1,000
James B. Jones 1,000
James B. Jones 1,000
John P. Longenecker 1,000
James S. Scibetta 1,000
Gary W. Pace 1,000
Mark A. Kronenfeld 1,000
Paul J. Hastings 1,000
Last 10 Sell Shares
David M. Stack 1,000
David M. Stack 1,000
David M. Stack 1,000
Lauren Riker 1,000
Kristen Marie Williams 1,000
Robert J. Weiland 1,000
Paul J. Hastings 1,000
Charles A. Reinhart 1,000
Richard Scranton 1,000
David M. Stack 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 80 80 80 80
Low Target Price Estimate 27 27 27 27
Mean Target Price Estimate 43.46 43.46 43.46 43.46
Standard Deviation 13.38 13.38 13.38 13.38
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 1
Hold 8 7 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.33 2.29 2.33 2.31